Vol. 3 No. 3 (2008)

Published: 2009-12-23

EDITORIAL

Role of Angiotensin and its Inhibition in Hypertension, Ischemic Heart Disease and Heart Failure

Haralambos Gavras

100-101
- PDF
Percutaneous Aortic Valve Replacement: Current Status and Future Perspective

Alec Vahanian

102-104
- PDF
A Paradigm Shift and New Therapeutic Options for the Metabolic Syndrome

Christodoulos Flordellis

105-106
- PDF

REVIEWS

Cardiac Pacemaker (If) Current: Physiological and Pharmacological Properties

Dario DiFrancesco

107-111
- PDF
ECG Changes and Voltage Attenuation in Congestive Heart Failure

John E Madias

112-115
- PDF
Stable Coronary Artery Disease: When is Percutaneous Coronary Intervention Indicated?

Demosthenes G Katritsis

116-120
- PDF
New Biochemical Markers of Ischemia: The Diagnostic and Prognostic Role of Brain Natriuretic Peptide, C-Reactive Protein, Ischemia Modified Albumin and Myeloperoxidase

Spyridon Koulouris, Stylianos Tzeis, Antonis S Manolis, MD, FACC, FESC, FHRS

121-127
- PDF
Metabolic Syndrome and Cardiovascular Risk: The Nurse's Role

Dimitra Agelidou

128-135
- PDF

ORIGINAL ARTICLES

Subclavian and Vertebral Artery Angioplasty - Vertebro-Basilar Insufficiency: Clinical Aspects and Diagnosis

Antonios Polydorou

136-140
- PDF

CASE REPORTS

Right External Iliac Vein Thrombosis After Percutaneous Transluminal Coronary Angioplasty

Andreas Mazarakis, Nikolaos Karouzos

141-142
- PDF